2
Announcements
Trials
Browse
Landscape
Status
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Prostatic Neoplasms
21
Carcinoma, Non-Small-Cell Lung
21
Breast Neoplasms
20
Neoplasms
19
Stomach Neoplasms
15
Colorectal Neoplasms
15
Lung Neoplasms
13
Endometrial Neoplasms
13
Pancreatic Neoplasms
11
Leukemia, Myeloid, Acute
10
Colonic Neoplasms
9
Carcinoma, Hepatocellular
9
Oropharyngeal Neoplasms
6
Neoplasm Metastasis
6
Multiple Myeloma
6
Melanoma
6
Lymphoma, Large B-Cell, Diffuse
6
Esophageal Neoplasms
6
Squamous Cell Carcinoma of Head and Neck
5
Sarcoma
5
Rectal Neoplasms
5
Mouth Neoplasms
5
Leukemia, Lymphocytic, Chronic, B-Cell
5
Head and Neck Neoplasms
5
Uterine Cervical Neoplasms
4
Recurrence
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Lymphoma, Mantle-Cell
4
Leukemia, Myelomonocytic, Acute
4
Leukemia, Monocytic, Acute
4
Interventions
Methylprednisolone
4
Etanercept
2
Bronchoscopy
2
Bronchoalveolar Lavage
2
Blood Specimen Collection
2
ziprasidone
1
tocilizumab
1
pirfenidone
1
ceftolozane, tazobactam drug combination
1
Zolpidem
1
XAV-19
1
X-Rays
1
Warfarin
1
Vecuronium Bromide
1
Vancomycin
1
Ultrasonography
1
Tranexamic Acid
1
Tobramycin
1
Thoracotomy
1
Thoracic Surgery, Video-Assisted
1
Surveys and Questionnaires
1
Standard of Care
1
Spironolactone
1
Sodium Bicarbonate
1
Sevelamer
1
Saline Solution
1
Rocuronium
1
Ribavirin
1
Prednisone
1
Piperacillin, Tazobactam Drug Combination
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Pneumonia
×
Observation
×
Clear all
NCT06192004
2026-05-04
LOOP
AstraZeneca
Terminated
83 enrolled